Playback speed
10 seconds
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Management With Bispecific Agents in MM and B-Cell NHL"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Monique Minnema
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Monique Minnema
0 views
June 7, 2024
Chapters
Introduction & Recommended Consensus Guidelines
00:00
FDA-Approved Bispecific Agents & Targets
01:11
Managing Cytokine Release Syndrome (CRS)
01:38
Tumor Flare & Injection Site Reactions
04:53
Cytopenias, Infections & Vaccination Strategies
06:40
Neurotoxicity & GPRC5D-Specific Toxicities
11:13
Patient Case Study & Take-Home Messages
14:56
Comments 0
Login to view comments.
Click here to Login